Anxiety Disorders Enrolling by Invitation Phase 2 Trials for Oxytocin (DB00107)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Enrolling by Invitation2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03593473Inhaled Oxytocin and HPA Axis ReactivityBasic Science